ApprovalTrail

Approval · Notice of Compliance 2806 · 1998

CYPROTERONE: Notice of Compliance 2806

Issued February 11, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2806
Date
February 11, 1998
Company
Bdh Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Therapeutic class
Antiandrogen
Canadian reference product
ANDROCUR (Berlex Canada Inc.)

Products in this notice

BrandDINStatus today
CYPROTERONE02237253Cancelled Post Market

Medicinal ingredients